Seer Insights Program
Advance translational proteomics research
The Seer Insights Translational Research Track supports investigators conducting proteomics research with a clear path toward improving understanding of human disease.
This track is designed for academic and translational researchers, particularly those without established in-house mass spectrometry proteomics capabilities, seeking to leverage deep, unbiased proteomic insights to advance studies in areas such as:
- Biomarker discovery
- Disease mechanism research
- Translational cohort studies
- Clinical research programs
Selected awardees will receive access to Seer’s Proteograph® workflow through the Seer Technology Access Center (STAC), enabling high-depth proteomic analysis to support translational discovery.
What to expect
Researchers are invited to submit a brief research proposal describing their study aims, experimental design, and how Seer’s proteomics technology will help address key scientific questions.
Proposals will be evaluated by a panel of scientific experts based on:
- Scientific merit
- Translational impact
- Alignment with Seer technology
- Experimental feasibility
The submission process is completed through a web-based application form and typically requires approximately 15–20 minutes to complete.
Proposals will undergo scientific review following the submission deadline, and one proposal will be selected for support through the 2026 Translational Research Track.
Program support
Selected investigators will receive a service grant supporting translational proteomics research using Seer’s Proteograph workflow.
Support provided through STAC includes:
- Access to Seer’s Proteograph® workflow for deep proteomic profiling
- Processing and analysis of up to 160 samples
- State-of-the-art mass spectrometry analysis performed at STAC
- Bioinformatics support for study analysis and interpretation
- Opportunity to present findings at a Seer-sponsored scientific session
This support is intended to enable completion of a high-impact translational proteomics research that advances understanding of human health and disease.
Timeline
- April 19, 2026 Applications open
- June 12, 2026 Submission deadline
Following the submission deadline, proposals will undergo scientific review and scoring. Selected awardees will be notified after completion of the review process.
Eligibility
Applicants must:
- Be affiliated with a recognized academic or research institution
- Propose a project with a clear translational research focus
- Demonstrate alignment between the study design and the capabilities of Seer’s Proteograph® technology
- Submit compatible sample types including plasma, serum, and/or cerebrospinal fluid (CSF)
- Not have established internal mass spectrometry-based proteomics workflows as a primary research capability or method for generating proteomic data.
Please review the Official Rules for more information.
Frequently Asked Questions
What types of projects are appropriate for this track?
This track supports translational proteomics projects that connect biological discovery to clinical insight, including but not limited to:
- Biomarker discovery
- Disease mechanism studies
- Clinical cohort analysis
- Cross-disciplinary translational programs
Projects should articulate how proteomic findings may advance understanding of human disease or improve clinical research strategies.
Who is eligible to apply for the Translational Research Track?
Applicants must be affiliated with a recognized academic or research institution within eligible territories (NA, EMEA, Japan, South Korea, and Australia unless otherwise specified in the Official Rules). Teams seeking to leverage deep, unbiased proteomic insights to advance studies are encouraged to apply, particularly those without established in-house mass spectrometry proteomics capabilities. Projects should demonstrate a clear translational focus and alignment with Proteograph capabilities.
What are the selection criteria?
Proposals are evaluated by scientific leaders from academia and industry, including members of Seer’s Scientific Advisory Board. Criteria include:
- Scientific merit and track record of the applicant
- Originality and rigor of the experimental approach
- Clear translational impact
- Alignment with Proteograph workflow capabilities
- Feasibility of project execution
Are selected participants required to present their findings?
Yes. Translational Research Track grant recipients are expected to present their findings at a mutually agreed Seer-sponsored scientific session or workshop.